Stay updated on TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Sign up to get notified when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.

Latest updates to the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe label text containing the contact information was capitalized from 'Find contact information' to 'Find Contact Information', and the revision entry was updated to 'v3.7.0' in the history, indicating UI consistency and the latest version reference.SummaryDifference0.2%

- Check33 days agoChange DetectedA new revision entry (v3.6.6) was added to the study record history, reflecting an updated version of the record, while the previous revision (v3.6.5) was removed from the latest list.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.6.5 has been added to the study history, and the previous v3.6.4 entry has been removed. This update reflects an updated version in the page’s history log.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the page's history, replacing the previous Revision: v3.6.3. This indicates a minor update to the revision metadata of the page and does not modify study content.SummaryDifference0.1%

- Check97 days agoChange DetectedA new revision entry (v3.6.3) was added to the study history. The previous revision (v3.6.0) was removed from the sequence.SummaryDifference0.1%

- Check104 days agoChange DetectedThe latest revision adds References, Study Design, and Study Status to the study record, updating the page to reflect current methodological details and citations. It also notes the removal of an earlier 2026-01-28 entry from the history.SummaryDifference0.5%

Stay in the know with updates to TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.